Article
Identification of Novel Drug Targets and Immune Response Biomarkers in HCMV-Infected Hosts
2023-02-23
Abstract excerpt
Human cytomegalovirus (HCMV) is a well known hallmark of increasing morbidity and mortality in humans with acquired impairment in innate and adaptive immunity indicating high seroprevalence rate of 83%. This study aims to identify novel drug targets as disease biomarkers in HCMV-infected hosts. Thereby datasets were collected from NCBI SRA Database and were further analyzed through RNA-seq pipeline to identify dif...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 12d696d8-d95d-5ca7-ba03-dd98b31bf2df
- DOI
- 10.21203/rs.3.rs-2608712/v1
